Glück Conviction Score™ ⓘ
ALEC
Alector, Inc.
Effektiv: Neutral
Niedrig
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
74,9
27 neu, 42 erhöht, 48,1M $ netto
Aktivist
14,8
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 2.22 | -31.0 % vs SMA50 | |
| Kurs vs SMA200 | Bärisch | 15 % | 2.09 | -26.8 % vs SMA200 | |
| SMA-Cross | Bullisch | 10 % | GOLDEN | vor 67 Tagen @ 2.19 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 1.87 | EMA50: 2.06 | |
| MACD-Histogramm | Bärisch | 10 % | -0.046 | Bearisch | |
| RSI(14) | Bullisch | 10 % | 26.5 | Überverkauft | |
| Stoch %K(14) | Bullisch | 5 % | 4.8 | Überverkauft | |
| ADX(14)+DI | Bärisch | 10 % | 36.2 | +DI: 9.8 / −DI: 32.6 | |
| Z-Score(60) | Bullisch | 5 % | -2.37 | Extrem überverkauft | |
| 52W-Position | Bärisch | 5 % | 17.9 % | Hoch 3.32 / Tief 1.14 | |
| Bollinger(20,2σ) | Bullisch | 5 % | 10.4 % | Upper 2.46 / Mid 1.94 / Lower 1.42 | |
| LinReg-Slope(60) | Neutral | 10 % | -0.0087 | R²=0.28 / annualisiert -99.7 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | Wong-Sarad Grace | Officer, Principal Accounting Officer | Open Market Sale | -3.475 | 1,88 | -6.542,73 | -14,3% | |
| 2026-06-02 | Wong-Sarad Grace | Officer, Principal Accounting Officer | Open Market Sale | -5.709 | 1,97 | -11.270,71 | -24,7% | |
| 2026-06-02 | Berkley Neil Lindsay | Officer, CFO & Chief Business Officer | Open Market Sale | -19.360 | 1,97 | -38.220,51 | -83,8% | |
| 2026-06-02 | Rosenthal Arnon | Director, Officer, Chief Executive Officer | Open Market Sale | -87.216 | 1,97 | -172.190,55 | -377,6% | |
| 2026-04-16 | Wong-Sarad Grace | Officer, Principal Accounting Officer | Open Market Sale | -1.820 | 2,65 | -4.823,00 | -10,6% | |
| 2026-03-10 | Wong-Sarad Grace | Officer, Principal Accounting Officer | Open Market Sale | -1.000 | 2,65 | -2.650,00 | -5,8% | |
| 2026-03-03 | Wong-Sarad Grace | Officer, Principal Accounting Officer | Open Market Sale | -3.367 | 2,08 | -7.012,11 | -15,4% | |
| 2026-03-02 | Berkley Neil Lindsay | Officer, CFO & Chief Business Officer | Open Market Sale | -29.649 | 2,12 | -62.953,72 | -138,0% | |
| 2026-03-02 | Wong-Sarad Grace | Officer, Principal Accounting Officer | Open Market Sale | -8.071 | 2,12 | -17.137,96 | -37,6% | |
| 2026-03-02 | Rosenthal Arnon | Director, Officer, Chief Executive Officer | Open Market Sale | -81.864 | 2,12 | -173.821,83 | -381,1% | |
| 2026-02-26 | Wong-Sarad Grace | Officer, Principal Accounting Officer | Open Market Sale | -4.079 | 2,50 | -10.197,50 | -22,4% | |
| 2025-12-05 | Wong-Sarad Grace | Officer, Principal Accounting Officer | Open Market Sale | -4.753 | 1,21 | -5.751,13 | -12,6% | |
| 2025-12-03 | Rosenthal Arnon | Director, Officer, Chief Executive Officer | Open Market Sale | -104.347 | 1,12 | -116.826,90 | -256,2% | |
| 2025-12-03 | Wong-Sarad Grace | Officer, Principal Accounting Officer | Open Market Sale | -8.056 | 1,12 | -9.018,69 | -19,8% | |
| 2025-12-03 | Kenkare-Mitra Sara | Officer, President and Head of R&D | Open Market Sale | -41.687 | 1,12 | -46.672,77 | -102,3% | |
| 2025-12-03 | Berkley Neil Lindsay | Officer, Chief Bus Ofcr & Interim CFO | Open Market Sale | -37.261 | 1,12 | -41.717,42 | -91,5% | |
| 2025-09-02 | Berkley Neil Lindsay | Officer, Principal Financial Officer | Open Market Sale | -15.842 | 2,50 | -39.554,31 | -86,7% | |
| 2025-09-02 | Rosenthal Arnon | Director, Officer, Chief Executive Officer | Open Market Sale | -51.562 | 2,50 | -128.740,00 | -282,3% | |
| 2025-09-02 | Kenkare-Mitra Sara | Officer, President and Head of R&D | Open Market Sale | -23.638 | 2,50 | -59.019,36 | -129,4% | |
| 2025-09-02 | Wong-Sarad Grace | Officer, Principal Accounting Officer | Open Market Sale | -5.910 | 2,50 | -14.756,09 | -32,4% | |
| 2025-08-26 | Hammond Paula | Director | Open Market Sale | -14.000 | 2,36 | -32.998,00 | -72,4% | |
| 2025-06-20 | Yaffe Kristine | Director | Open Market Sale | -1.000 | 1,44 | -1.440,00 | -3,2% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 10.000.000 | 10.000.000 | 0 | 21.500.000 | Unverändert | 0,0% | |
| BlackRock, Inc. | 7.741.245 | 7.147.766 | 593.479 | 16.643.677 | Aufgestockt | +8,3% | |
| VANGUARD GROUP INC | 6.908.054 | 0 | 6.908.054 | 10.776.564 | Neu | +100,0% | |
| Foresite Capital Management IV, LLC | 3.887.200 | 3.887.200 | 0 | 8.357.480 | Unverändert | 0,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.678.722 | 0 | 3.678.722 | 7.909.252 | Neu | +100,0% | |
| Merck & Co., Inc. | 3.545.719 | 3.545.719 | 0 | 7.623.297 | Unverändert | 0,0% | |
| D. E. Shaw & Co., Inc. | 3.332.835 | 2.365.151 | 967.684 | 7.165.596 | Aufgestockt | +40,9% | |
| 683 Capital Management, LLC | 3.200.000 | 3.350.000 | -150.000 | 6.880.000 | Reduziert | -4,5% | |
| BALYASNY ASSET MANAGEMENT L.P. | 2.935.253 | 3.265.575 | -330.322 | 6.310.794 | Reduziert | -10,1% | |
| Nantahala Capital Management, LLC | 2.815.983 | 0 | 2.815.983 | 6.054.363 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 2.286.218 | 2.075.220 | 210.998 | 4.916.361 | Aufgestockt | +10,2% | |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2.154.361 | 2.173.202 | -18.841 | 4.631.876 | Reduziert | -0,9% | |
| Spruce Street Capital LP | 2.101.068 | 1.117.986 | 983.082 | 4.517.296 | Aufgestockt | +87,9% | |
| Ikarian Capital, LLC | 2.082.606 | 2.082.606 | 0 | 4.477.603 | Unverändert | 0,0% | |
| Kynam Capital Management, LP | 2.000.000 | 2.000.000 | 0 | 4.300.000 | Unverändert | 0,0% | |
| MILLENNIUM MANAGEMENT LLC | 1.979.226 | 1.332.914 | 646.312 | 4.255.336 | Aufgestockt | +48,5% | |
| STATE STREET CORP | 1.865.526 | 1.814.298 | 51.228 | 4.010.881 | Aufgestockt | +2,8% | |
| FMR LLC | 1.796.104 | 2.231.171 | -435.067 | 3.861.624 | Reduziert | -19,5% | |
| MEDICI CAPITAL LLC | 1.652.520 | 1.500.520 | 152.000 | 3.552.918 | Aufgestockt | +10,1% | |
| Eversept Partners, LP | 1.351.106 | 1.006.163 | 344.943 | 2.904.878 | Aufgestockt | +34,3% | |
| Euclidean Capital LLC | 1.307.858 | 1.307.858 | 0 | 2.811.895 | Unverändert | 0,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 1.287.691 | 1.543.650 | -255.959 | 2.768.536 | Reduziert | -16,6% | |
| TWO SIGMA INVESTMENTS, LP | 1.279.306 | 1.039.656 | 239.650 | 2.750.508 | Aufgestockt | +23,1% | |
| DEUTSCHE BANK AG\ | 1.092.903 | 1.035.154 | 57.749 | 2.349.741 | Aufgestockt | +5,6% | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1.055.192 | 1.055.192 | 0 | 2.268.663 | Unverändert | 0,0% | |
| ADAR1 Capital Management, LLC | 1.050.000 | 1.108.000 | -58.000 | 2.257.500 | Reduziert | -5,2% | |
| DAFNA Capital Management LLC | 908.351 | 908.351 | 0 | 1.952.955 | Unverändert | 0,0% | |
| Elmind Capital, LP | 900.000 | 900.000 | 0 | 1.935.000 | Unverändert | 0,0% | |
| MACKENZIE FINANCIAL CORP | 857.354 | 660.168 | 197.186 | 1.843.311 | Aufgestockt | +29,9% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 787.408 | 665.491 | 121.917 | 1.692.927 | Aufgestockt | +18,3% | |
| AQR CAPITAL MANAGEMENT LLC | 711.334 | 599.569 | 111.765 | 1.529.368 | Aufgestockt | +18,6% | |
| NORTHERN TRUST CORP | 692.256 | 587.653 | 104.603 | 1.488.351 | Aufgestockt | +17,8% | |
| MARSHALL WACE, LLP | 620.424 | 1.166.817 | -546.393 | 1.333.914 | Reduziert | -46,8% | |
| GOLDMAN SACHS GROUP INC | 604.562 | 437.959 | 166.603 | 1.299.809 | Aufgestockt | +38,0% | |
| PANAGORA ASSET MANAGEMENT INC | 590.388 | 850.298 | -259.910 | 1.269.334 | Reduziert | -30,6% | |
| XTX Topco Ltd | 559.896 | 592.839 | -32.943 | 1.203.776 | Reduziert | -5,6% | |
| BOOTHBAY FUND MANAGEMENT, LLC | 559.726 | 559.726 | 0 | 1.203.411 | Unverändert | 0,0% | |
| Vestal Point Capital, LP | 755.000 | 0 | 755.000 | 1.177.800 | Neu | +100,0% | |
| Affinity Asset Advisors, LLC | 500.000 | 0 | 500.000 | 1.075.000 | Neu | +100,0% | |
| TWO SIGMA ADVISERS, LP | 651.800 | 0 | 651.800 | 1.016.808 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 431.264 | 1.006.513 | -575.249 | 927.218 | Reduziert | -57,2% | |
| BANK OF AMERICA CORP /DE/ | 380.908 | 134.506 | 246.402 | 818.951 | Aufgestockt | +183,2% | |
| MORGAN STANLEY | 364.567 | 319.072 | 45.495 | 783.821 | Aufgestockt | +14,3% | |
| DIMENSIONAL FUND ADVISORS LP | 283.817 | 199.126 | 84.691 | 609.754 | Aufgestockt | +42,5% | |
| AMERIPRISE FINANCIAL INC | 271.272 | 354.299 | -83.027 | 583.234 | Reduziert | -23,4% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 269.297 | 570.280 | -300.983 | 578.989 | Reduziert | -52,8% | |
| Invesco Ltd. | 265.067 | 279.468 | -14.401 | 569.893 | Reduziert | -5,2% | |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 200.000 | 200.000 | 0 | 430.000 | Unverändert | 0,0% | |
| CANADA PENSION PLAN INVESTMENT BOARD | 183.200 | 172.300 | 10.900 | 393.880 | Aufgestockt | +6,3% | |
| Nuveen, LLC | 154.930 | 133.248 | 21.682 | 333.100 | Aufgestockt | +16,3% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 10.000.000 | 10.000.000 | 0,0% | 21.500.000 | 12,33 |
| BlackRock, Inc. | 7.741.245 | 7.147.766 | +8,3% | 16.643.677 | 9,55 |
| Foresite Capital Management IV, LLC | 3.887.200 | 3.887.200 | 0,0% | 8.357.480 | 4,79 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.678.722 | 0 | +100,0% | 7.909.252 | 4,54 |
| Merck & Co., Inc. | 3.545.719 | 3.545.719 | 0,0% | 7.623.297 | 4,37 |
| D. E. Shaw & Co., Inc. | 3.332.835 | 2.365.151 | +40,9% | 7.165.596 | 4,11 |
| 683 Capital Management, LLC | 3.200.000 | 3.350.000 | -4,5% | 6.880.000 | 3,95 |
| BALYASNY ASSET MANAGEMENT L.P. | 2.935.253 | 3.265.575 | -10,1% | 6.310.794 | 3,62 |
| Nantahala Capital Management, LLC | 2.815.983 | 0 | +100,0% | 6.054.363 | 3,47 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.286.218 | 2.075.220 | +10,2% | 4.916.361 | 2,82 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2.154.361 | 2.173.202 | -0,9% | 4.631.876 | 2,66 |
| Spruce Street Capital LP | 2.101.068 | 1.117.986 | +87,9% | 4.517.296 | 2,59 |
| Ikarian Capital, LLC | 2.082.606 | 2.082.606 | 0,0% | 4.477.603 | 2,57 |
| Kynam Capital Management, LP | 2.000.000 | 2.000.000 | 0,0% | 4.300.000 | 2,47 |
| MILLENNIUM MANAGEMENT LLC | 1.979.226 | 1.332.914 | +48,5% | 4.255.336 | 2,44 |
| STATE STREET CORP | 1.865.526 | 1.814.298 | +2,8% | 4.010.881 | 2,30 |
| FMR LLC | 1.796.104 | 2.231.171 | -19,5% | 3.861.624 | 2,22 |
| MEDICI CAPITAL LLC | 1.652.520 | 1.500.520 | +10,1% | 3.552.918 | 2,04 |
| Eversept Partners, LP | 1.351.106 | 1.006.163 | +34,3% | 2.904.878 | 1,67 |
| Euclidean Capital LLC | 1.307.858 | 1.307.858 | 0,0% | 2.811.895 | 1,61 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 137 | 92,2 | 190 |
| 31.12.2025 | ✓ | 130 | 86,9 | 234 |
| 30.09.2025 | ✓ | 150 | 77,5 | 291 |
| 30.06.2025 | ✓ | 136 | 71,1 | 125 |
| 31.03.2025 | ✓ | 141 | 74,5 | 120 |
| 31.12.2024 | ✓ | 150 | 75,7 | 187 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| TCG Crossover Management, LLC | 10.000.000 | 15.600.000 |
| Foresite Capital Management IV, LLC | 3.887.200 | 6.064.032 |
| BALYASNY ASSET MANAGEMENT L.P. | 3.265.575 | 5.094.297 |
| Kynam Capital Management, LP | 2.000.000 | 3.120.000 |
| Spruce Street Capital LP | 1.117.986 | 1.744.058 |
| ADAR1 Capital Management, LLC | 1.108.000 | 1.728.480 |
| Elmind Capital, LP | 900.000 | 1.404.000 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 200.000 | 312.000 |
| CANADA PENSION PLAN INVESTMENT BOARD | 172.300 | 268.788 |
| Graham Capital Management, L.P. | 104.851 | 163.568 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| 683 Capital Management, LLC | 3.350.000 | 2.350.000 | +235.0 % | 5.226.000 |
| D. E. Shaw & Co., Inc. | 2.365.151 | 1.386.947 | +141.8 % | 3.689.636 |
| Ikarian Capital, LLC | 2.082.606 | 1.322.606 | +174.0 % | 3.248.866 |
| ACADIAN ASSET MANAGEMENT LLC | 3.442.449 | 1.069.464 | +45.1 % | 5.362 |
| MEDICI CAPITAL LLC | 1.500.520 | 1.018.546 | +211.3 % | 2.340.811 |
| MARSHALL WACE, LLP | 1.166.817 | 1.015.174 | +669.4 % | 1.820.234 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2.173.202 | 942.228 | +76.5 % | 3.390.195 |
| VANGUARD GROUP INC | 6.908.054 | 873.395 | +14.5 % | 10.776.564 |
| TWO SIGMA INVESTMENTS, LP | 1.039.656 | 732.477 | +238.5 % | 1.621.863 |
| JANE STREET GROUP, LLC | 1.006.513 | 656.282 | +187.4 % | 1.570.160 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| FMR LLC | 2.231.171 | -12.950.678 | -85.3 % | 3.480.627 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 56.203 | -2.128.829 | -97.4 % | 89 |
| ROYAL BANK OF CANADA | 4.678 | -623.974 | -99.3 % | 7.000 |
| Eversept Partners, LP | 1.006.163 | -482.562 | -32.4 % | 1.569.614 |
| BARCLAYS PLC | 398.687 | -474.688 | -54.4 % | 621.952 |
| CITADEL ADVISORS LLC | 179.947 | -372.334 | -67.4 % | 280.718 |
| Vestal Point Capital, LP | 755.000 | -225.000 | -23.0 % | 1.177.800 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 28.829 | -187.745 | -86.7 % | 44.973 |
| GOLDMAN SACHS GROUP INC | 437.959 | -171.950 | -28.2 % | 683.217 |
| MORGAN STANLEY | 319.072 | -115.096 | -26.5 % | 497.753 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 14.05.2026 | Polaris Venture Management Co VI, L.L.C. | Passiv (13G/A) | 4,40 % | 4.853.817 | -1,90 pp | |
| 14.05.2026 | Amir Nashat | Passiv (13G/A) | 4,50 % | 4.985.149 | -1,90 pp | |
| 14.05.2026 | Terrance G. McGuire | Passiv (13G/A) | 4,70 % | 5.173.499 | -1,80 pp | |
| 14.05.2026 | Brian Chee | Passiv (13G/A) | 4,40 % | 4.853.817 | -1,90 pp | |
| 14.05.2026 | Bryce Youngren | Passiv (13G/A) | 4,40 % | 4.865.681 | -2,00 pp | |
| 14.05.2026 | David Barrett | Passiv (13G/A) | 4,40 % | 4.853.817 | -1,90 pp | |
| 14.05.2026 | Polaris Venture Partners VI, L.P. | Passiv (13G/A) | 0,50 % | 498.468 | 0,00 pp | |
| 14.05.2026 | Polaris Venture Partners VI (AIV), L.P. | Passiv (13G/A) | 3,00 % | 3.280.842 | -1,40 pp | |
| 14.05.2026 | Polaris Venture Partners VI (AIV-B), L.P. | Passiv (13G/A) | 0,70 % | 806.528 | -0,40 pp | |
| 14.05.2026 | Polaris Venture Partners Founders' Fund VI, L.P. | Passiv (13G/A) | 0,20 % | 267.979 | -0,10 pp | |
| 14.05.2026 | Jonathan A. Flint | Passiv (13G/A) | 4,40 % | 4.892.941 | -1,90 pp | |
| 27.04.2026 | BlackRock, Inc. | Passiv (13G) | 5,20 % | 5.784.214 | +0,50 pp | |
| 26.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -6,32 pp | |
| 17.02.2026 | Roderick Wong | Passiv (13G/A) | Ausstieg | 0 | -6,90 pp | |
| 17.02.2026 | RTW Investments, LP | Passiv (13G/A) | Ausstieg | 0 | -6,90 pp | |
| 06.02.2026 | Arnon Rosenthal | Passiv (13G/A) | 7,40 % | 8.213.925 | +7,40 pp | |
| 30.01.2026 | The Vanguard Group | Passiv (13G/A) | 6,32 % | 6.908.054 | +1,11 pp | |
| 21.01.2026 | BlackRock, Inc. | Passiv (13G/A) | 4,70 % | 5.179.805 | -0,40 pp | |
| 14.11.2025 | RTW Investments, LP | Passiv (13G) | 6,90 % | 6.990.806 | Neu | |
| 14.11.2025 | Roderick Wong | Passiv (13G) | 6,90 % | 6.990.806 | Neu | |
| 14.11.2025 | TCG Crossover Fund II, L.P. | Passiv (13G) | 4,60 % | 5.000.000 | Neu | |
| 14.11.2025 | Chen Yu | Passiv (13G) | 9,20 % | 10.000.000 | Neu | |
| 14.11.2025 | TCG Crossover GP II, LLC | Passiv (13G) | 4,60 % | 5.000.000 | Neu | |
| 14.11.2025 | TCG Crossover GP III, LLC | Passiv (13G) | 4,60 % | 5.000.000 | Neu | |
| 14.11.2025 | TCG Crossover Fund III, L.P. | Passiv (13G) | 4,60 % | 5.000.000 | Neu | |
| 13.11.2025 | Polaris Venture Partners VI (AIV-B), L.P. | Passiv (13G/A) | 1,10 % | 1.179.383 | Neu | |
| 13.11.2025 | Polaris Venture Management Co VI, L.L.C. | Passiv (13G/A) | 6,30 % | 6.853.817 | -12,40 pp | |
| 13.11.2025 | Polaris Venture Partners VI, L.P. | Passiv (13G/A) | 0,50 % | 498.468 | -0,20 pp | |
| 13.11.2025 | Bryce Youngren | Passiv (13G/A) | 6,40 % | 6.945.149 | -12,30 pp | |
| 13.11.2025 | Polaris Venture Partners VI (AIV), L.P. | Passiv (13G/A) | 4,40 % | 4.797.563 | -9,20 pp | |
| 13.11.2025 | Polaris Venture Partners Founders' Fund VI, L.P. | Passiv (13G/A) | 0,30 % | 378.403 | Neu | |
| 13.11.2025 | Terrance G. McGuire | Passiv (13G/A) | 6,50 % | 7.095.251 | -12,20 pp | |
| 13.11.2025 | Brian Chee | Passiv (13G/A) | 6,30 % | 6.880.084 | -12,40 pp | |
| 13.11.2025 | Amir Nashat | Passiv (13G/A) | 6,40 % | 6.932.617 | -12,30 pp | |
| 13.11.2025 | David Barrett | Passiv (13G/A) | 6,30 % | 6.880.071 | -12,40 pp | |
| 13.11.2025 | Jonathan A. Flint | Passiv (13G/A) | 6,30 % | 6.892.942 | -12,40 pp | |
| 07.11.2025 | Abigail P. Johnson | Passiv (13G/A) | 3,60 % | 3.599.820 | Neu | |
| 07.11.2025 | FMR LLC | Passiv (13G/A) | 3,60 % | 3.599.820 | Neu | |
| 17.10.2025 | BlackRock, Inc. | Passiv (13G/A) | 5,10 % | 5.201.092 | -1,10 pp | |
| 14.08.2025 | Rajeev Shah | Passiv (13G/A) | Ausstieg | 0 | -9,90 pp |
Stammdaten
Alector, Inc., ein klinisches Biopharmaunternehmen, entwickelt Therapien zur Behandlung von neurodegenerativen Erkrankungen. Seine Produkte umfassen AL001, einen humanisierten rekombinanten monoklonalen Antikörper, der sich in Phase-III-Klinikstudien zur Behandlung von Stirnlappendemenz, Alzheimer-, Parkinson- und Amyotrophe-Lateralsklerose-Erkrankungen befindet; und AL101, das sich in Phase-I-Klinikstudien zur Behandlung neurodegenerativer Erkrankungen, einschließlich Alzheimer und Parkinson, befindet. Das Unternehmen bietet auch AL002, einen Produktkandidaten, der sich in Phase-II-Klinikstudien zur Behandlung der Alzheimer-Krankheit befindet; und AL003, das sich in Phase-I-Klinikstudien zur Behandlung der Alzheimer-Krankheit befindet. Darüber hinaus umfassen seine in Entwicklung befindlichen Produkte AL044, das auf MS4A4A abzielt, ein Risikogen für die Alzheimer-Krankheit. Alector, Inc. hat eine Kooperationsvereinbarung mit Adimab, LLC für Forschung und Entwicklung von Antikörpern; und eine strategische Kooperationsvereinbarung mit GlaxoSmithKline plc für die Entwicklung und Vermarktung monoklonaler Antikörper wie AL001 und AL101 zur Behandlung neurodegenerativer Erkrankungen. Das Unternehmen wurde 2013 gegründet und hat seinen Hauptsitz in South San Francisco, Kalifornien.
Unternehmen & Branche
| Name | Alector, Inc. |
|---|---|
| Ticker | ALEC |
| CIK | 0001653087 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 014442107 |
|---|---|
| ISIN | US0144421072 |
| Typ | Common Stock |
| Marktkapitalisierung | 173,3 Mio. USD |
| Beta | 0,62 |
Bewertung
| KBV (P/B) | 5,65 vs. 5,63 (2021) ≈ |
|---|---|
| KUV (P/S) | 8,23 vs. 8,18 (2021) ≈ |
| FCF-Rendite | -106,2 % vs. 17,4 % (2021) ▼ |
Qualität & Bilanz
| Operative Marge | -741,3 % vs. -18,0 % (2021) ▼ |
|---|---|
| Nettomarge | -679,2 % vs. -17,5 % (2021) ▼ |
| ROIC | -213,7 % vs. -10,4 % (2021) ▼ |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 5,63 | 3,57 | 5,05 | 1,48 | 5,62 | |
| KUV (P/S) | 8,18 | 5,73 | 6,98 | 1,86 | 8,18 | |
| FCF-Rendite | 17,4 % | -3,2 % | -27,5 % | -123,4 % | -106,9 % | |
| Qualität & Bilanz | ||||||
| Operative Marge | -18,0 % | -103,2 % | -156,3 % | -144,2 % | -741,3 % | |
| Nettomarge | -17,5 % | -99,8 % | -134,3 % | -118,4 % | -679,2 % | |
| ROIC | -10,4 % | -51,7 % | -75,3 % | -70,3 % | -213,7 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 1.046.000 | -22.930.000 | -0,21 | 239.916.000 | 10.382.000 |
| 2025-12-31 | 10-K | 21.045.000 | -142.929.000 | -1,39 | 293.237.000 | 30.649.000 |
| 2025-09-30 | 10-Q | 3.260.000 | -34.667.000 | -0,34 | 335.285.000 | 57.712.000 |
| 2025-06-30 | 10-Q | 7.874.000 | -30.524.000 | -0,30 | 356.422.000 | 71.175.000 |
| 2025-03-31 | 10-Q | 3.700.000 | -40.471.000 | -0,41 | 408.303.000 | 94.610.000 |
| 2024-12-31 | 10-K | 100.558.000 | -119.049.000 | -1,23 | 468.303.000 | 126.800.000 |
| 2024-09-30 | 10-Q | 15.342.000 | -42.220.000 | -0,43 | 516.023.000 | 118.933.000 |
| 2024-06-30 | 10-Q | 15.083.000 | -38.676.000 | -0,40 | 570.729.000 | 150.567.000 |
| 2024-03-31 | 10-Q | 15.900.000 | -36.079.000 | -0,38 | 635.494.000 | 178.907.000 |
| 2023-12-31 | 10-K | 97.100.000 | -130.391.000 | -1,56 | 621.827.000 | 134.158.000 |
| 2023-09-30 | 10-Q | 9.109.000 | -44.475.000 | -0,53 | 672.395.000 | 162.555.000 |
| 2023-06-30 | 10-Q | 56.214.000 | 1.375.000 | 0,02 | 708.737.000 | 196.306.000 |
| 2023-03-31 | 10-Q | 16.549.000 | -45.857.000 | -0,55 | 748.342.000 | 183.015.000 |
| 2022-12-31 | 10-K | 133.600.000 | -133.310.000 | -1,62 | 787.648.000 | 214.442.000 |
| 2022-09-30 | 10-Q | 14.852.000 | -46.148.000 | -0,56 | 837.038.000 | 253.104.000 |
| 2022-06-30 | 10-Q | 79.851.000 | 9.883.000 | 0,12 | 889.672.000 | 288.516.000 |
| 2022-03-31 | 10-Q | 24.474.000 | -44.617.000 | -0,54 | 954.457.000 | 267.537.000 |
| 2021-12-31 | 10-K | 207.085.000 | -36.329.000 | -0,45 | 814.658.000 | 300.724.000 |
| 2021-09-30 | 10-Q | 182.413.000 | 126.597.000 | 1,49 | 854.226.000 | 335.890.000 |
| 2021-06-30 | 10-Q | 6.568.000 | -55.147.000 | -0,69 | 397.113.000 | 184.515.000 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 07.05.2026 | 1,0 Mio. USD | -0,21 |
| Q3 2025 | 30.09.2025 | 06.11.2025 | 3,3 Mio. USD | -0,34 |
| Q2 2025 | 30.06.2025 | 06.11.2025 | 7,9 Mio. USD | -0,30 |
| Q1 2025 | 31.03.2025 | 07.05.2026 | 3,7 Mio. USD | -0,41 |
| Q3 2024 | 30.09.2024 | 06.11.2025 | 15,3 Mio. USD | -0,43 |
| Q2 2024 | 30.06.2024 | 06.11.2025 | 15,1 Mio. USD | -0,40 |
| Q1 2024 | 31.03.2024 | 06.11.2025 | 15,9 Mio. USD | -0,38 |
| Q3 2023 | 30.09.2023 | 06.11.2024 | 9,1 Mio. USD | -0,53 |
| Q2 2023 | 30.06.2023 | 06.11.2024 | 56,2 Mio. USD | 0,02 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 07.05.2026 | 10-Q | – | – | SEC » |
| 25.02.2026 | 10-K | 31.12.2025 | 56 Tage | SEC » |
| 06.11.2025 | 10-Q | 30.09.2025 | 37 Tage | SEC » |
| 07.08.2025 | 10-Q | 30.06.2025 | 38 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 26.02.2025 | 10-K | 31.12.2024 | 57 Tage | SEC » |
| 06.11.2024 | 10-Q | 30.09.2024 | 37 Tage | SEC » |
| 07.08.2024 | 10-Q | 30.06.2024 | 38 Tage | SEC » |
| 08.05.2024 | 10-Q | 31.03.2024 | 38 Tage | SEC » |
| 27.02.2024 | 10-K | 31.12.2023 | 58 Tage | SEC » |
| 07.11.2023 | 10-Q | 30.09.2023 | 38 Tage | SEC » |
| 03.08.2023 | 10-Q | 30.06.2023 | 34 Tage | SEC » |
| 04.05.2023 | 10-Q | 31.03.2023 | 34 Tage | SEC » |
| 28.02.2023 | 10-K | 31.12.2022 | 59 Tage | SEC » |
| 08.11.2022 | 10-Q | 30.09.2022 | 39 Tage | SEC » |
| 04.08.2022 | 10-Q | 30.06.2022 | 35 Tage | SEC » |
| 05.05.2022 | 10-Q | 31.03.2022 | 35 Tage | SEC » |
| 24.02.2022 | 10-K | 31.12.2021 | 55 Tage | SEC » |
| 04.11.2021 | 10-Q | 30.09.2021 | 35 Tage | SEC » |
| 03.08.2021 | 10-Q | 30.06.2021 | 34 Tage | SEC » |
| 05.05.2021 | 10-Q | 31.03.2021 | 35 Tage | SEC » |
| 29.03.2021 | 10-K/A | 31.12.2020 | 88 Tage | SEC » |
| 25.02.2021 | 10-K | 31.12.2020 | 56 Tage | SEC » |
| 10.11.2020 | 10-Q | 30.09.2020 | 41 Tage | SEC » |
| 11.08.2020 | 10-Q | 30.06.2020 | 42 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 12.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of… |
| 21.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | t of, or that are associated with, the reduction. Item 5.02 Departure of Directors or Certain Officers; Election of… |
| 28.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | (a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |
| 29.03.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 07.02.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 03.01.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Separation Agreement… |
| 15.12.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 08.09.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 07.09.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. A copy of the Company’s press release announcing the foregoing leadership changes together with the… |
| 26.03.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 05.03.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 24.03.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-13 | 745 | 2,16 | 1.609 |
| 2026-04-30 | 308 | 2,30 | 708 |
| 2026-04-24 | 6 | 2,43 | 15 |
| 2026-04-23 | 2.359 | 2,45 | 5.780 |
| 2026-04-15 | 3.627 | 2,41 | 8.741 |
| 2026-04-07 | 198 | 2,35 | 465 |
| 2026-03-05 | 1 | 2,15 | 2 |
| 2026-03-03 | 1.242 | 2,21 | 2.745 |
| 2026-02-10 | 4.022 | 1,96 | 7.883 |
| 2026-02-09 | 2.572 | 1,96 | 5.041 |
| 2026-02-06 | 2.572 | 1,82 | 4.681 |
| 2026-02-04 | 1.218 | 1,93 | 2.351 |
| 2026-01-21 | 2 | 1,83 | 4 |
| 2026-01-12 | 5 | 1,86 | 9 |
| 2026-01-05 | 656 | 1,53 | 1.004 |
| 2026-01-02 | 788 | 1,56 | 1.229 |
| 2025-12-29 | 380 | 1,45 | 551 |
| 2025-12-22 | 2.572 | 1,40 | 3.601 |